Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study-Reference-Cited by-同舟云学术

Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study

Published:2014-07-29 Issue:5 Volume:45 Page:501-513
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Kumada Hiromitsu¹,Hayashi Norio²,Izumi Namiki³,Okanoue Takeshi⁴,Tsubouchi Hirohito⁵,Yatsuhashi Hiroshi⁶,Kato Mai⁷,Rito Ki⁷,Komada Yuji⁸,Seto Chiharu⁷,Goto Shoichiro⁷

Affiliation:

1. Toranomon Hospital; Tokyo Japan

2. Kansai-Rosai Hospital; Hyogo Japan

3. Musashino Red Cross Hospital; Tokyo Japan

4. Saiseikai Suita Hospital; Osaka Japan

5. Kagoshima University Medical and Dental Hospital; Kagoshima Japan

6. National Hospital Organization Nagasaki Medical Center; Nagasaki Japan

7. Research and Development; Clinical Science Division; Janssen Pharmaceutical K.K.; Tokyo Japan

8. Research and Development; Japan Clinical Operations Division; Janssen Pharmaceutical K.K.; Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12375/fullpdf

Reference32 articles.

1. Changing trends in hepatitis C infection over the past 50 years in Japan;Chung;Intervirology,2010

2. The global burden of hepatitis C;Lavanchy;Liver Int,2009

3. Hepatocellular carcinoma in the Asia pacific region;Yuen;J Gastroenterol Hepatol,2009

4. Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology;Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology;Hepatol Res,2013

5. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J Hepatol,2011

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the cost‐effectiveness of screening for hepatitis C virus infection in Japan;Hepatology Research;2020-01-22

2. Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment era;Immunological Reviews;2018-08-11

3. Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study;Hepatology Research;2017-08-10

4. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C;Journal of Viral Hepatitis;2017-07-29

5. Current therapy for chronic hepatitis C: The role of direct-acting antivirals;Antiviral Research;2017-06